Back
RF Capital Group Vs. NovoCure Industry Stock Comparison
Sell
44
RCG.TO
RF Capital Group
Last Price:
$7.59
Seasonality Move:
5.05%
Sell
49
NVCR
NovoCure
Last Price:
$30.18
Seasonality Move:
-3.69%
Sell
44
RF Capital Group (RCG.TO)
is a Sell
Is RF Capital Group a Buy, Sell or Hold?
-
The current RF Capital Group [RCG.TO] share price is $7.59. The Score for RCG.TO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
RCG.TO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
-
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RCG.TO Stock Price Chart
What is RF Capital Group's stock price today?
-
The RF Capital Group share price today is $7.59Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RCG.TO is experiencing selling pressure, which indicates risk of future bearish movement.
NVCR Stock Price Chart
RCG.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 55.46 | Buy |
Chaikin Money Flow: | -300 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.28 - 7.56) | Buy |
Bollinger Bands (100): | (7.28 - 7.72) | Buy |
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.94 | Buy |
Relative Strength Index (14 RSI): | 58.79 | Buy |
Chaikin Money Flow: | -60501 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.36 - 32.64) | Buy |
Bollinger Bands (100): | (14.38 - 25.86) | Buy |
RCG.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.48 | Buy |
20-day SMA: | 7.47 | Buy |
50-day SMA: | 7.48 | Buy |
200-day SMA: | 7.5 | Buy |
8-day EMA: | 7.51 | Buy |
20-day EMA: | 7.46 | Buy |
50-day EMA: | 7.46 | Buy |
200-day EMA: | 7.6 | Sell |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.52 | Sell |
20-day SMA: | 30.41 | Sell |
50-day SMA: | 23.25 | Buy |
200-day SMA: | 18.89 | Buy |
8-day EMA: | 30.36 | Sell |
20-day EMA: | 29.22 | Buy |
50-day EMA: | 25.18 | Buy |
200-day EMA: | 21.21 | Buy |
RF Capital Group Earnings Growth & RCG.TO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.48 per share.
NovoCure Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.
RF Capital Group Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
18 | 19 | 20 | 23 | 24 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovoCure Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |